ODS Analytical Methods and Reference Materials Program-Dietary Supplement Element Methodology Workshop; Notice, 4046-4047 [E9-1162]

Download as PDF 4046 Federal Register / Vol. 74, No. 13 / Thursday, January 22, 2009 / Notices The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Mechanism of Immunological Tolerance. Date: February 19, 2009. Time: 10 a.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817. Contact Person: Cheryl K. Lapham, PhD, Scientific Review Administrator, Scientific Review Program, DEA, NIAID/NIH/DHHS, 6700–B Rockledge Drive, MSC 7616, Room 3127, Bethesda, MD 20892–7616, 301–402– 4598, clapham@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: January 13, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–1156 Filed 1–21–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health rmajette on PRODPC74 with NOTICES National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Nov<24>2008 14:47 Jan 21, 2009 Jkt 217001 Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; The NIDDK-KUH Fellowship Review Committee. Date: February 2, 2009. Time: 10 a.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Xiaodu Guo, MD, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 761, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–4719, guox@extra.niddk.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Digestive Diseases and Nutrition Fellowships. Date: February 19, 2009. Time: 9 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Churchill Hotel, 1914 Connecticut Avenue, NW., Washington, DC 20009. Contact Person: Thomas A. Tatham, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 760, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–3993, tathamt@mail.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK Ancillary Studies in Kidney Diseases. Date: March 2, 2009. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Thomas A. Tatham, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 760, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–3993, tathamt@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: January 13, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–1160 Filed 1–21–09; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health ODS Analytical Methods and Reference Materials Program—Dietary Supplement Element Methodology Workshop; Notice Notice is hereby given of the National Institutes of Health (NIH) Office of Dietary Supplements (ODS) Analytical Methods and Reference Materials Program, Dietary Supplement Element Methodology Workshop to be held Monday, March 23rd and Tuesday, March 24th, 2009 at the Marriott Gaithersburg Washingtonian Center Hotel in Gaithersburg, Maryland, 20878. Summary: Late in 2001, the U.S. Congress addressed the need for support of analytical methods and reference materials development related to dietary supplements. The Congressional appropriation language supported an increased ODS budget for several topics, including analytical methods and reference materials. The Senate language called for: ‘‘ODS to allocate sufficient funds to speed up an ongoing collaborative effort to develop and disseminate validated analytical methods and reference materials for the most commonly used botanicals and other dietary supplements.’’ On February 8, 2002, ODS held a public meeting to solicit comments to assist ODS in designing an overall strategy for implementing the Congressional mandate to foster development and validation of analytical methods and reference materials for dietary supplements. In Fiscal Years 2004 and 2005, Congress again used similar language supporting the Analytical Methods and Reference Materials Program in the ODS appropriations. On September 10, 2007, ODS held a Stakeholders’ Meeting to review the progress that had been made by the Analytical Methods and Reference Materials Program since its inception in 2002 and to receive comments on future programmatic directions. As a follow-up to the recommendations from the Stakeholders’ Meeting, a Vitamin Methodology Workshop was held in July 2008. This workshop sought to evaluate the state of analytical methodology on vitamins suitable for dietary supplements and to identify gaps in the analytical science for the purpose of meeting future methods needs of stakeholders. Results of the Vitamin Methodology Workshop include an executive summary of the E:\FR\FM\22JAN1.SGM 22JAN1 Federal Register / Vol. 74, No. 13 / Thursday, January 22, 2009 / Notices outcome of the workshop (in preparation) as well as recognition of a need for a Dietary Supplement Element Methodology Workshop. The purpose of this upcoming workshop is to evaluate the state of analytical methods for nutrient and nonnutrient minerals (including toxic elements) in dietary supplement products and to identify gaps in methodology, with a view toward designing a research program to fill the unmet methods needs of stakeholders. The desired outcomes of this meeting are to provide an overview of the status of analytical methodology for elements, to discuss analytical method purpose statements, to discuss the definition and evaluation of a method’s purpose, as well as its fitness for purpose. The sponsor of this meeting is the NIH Office of Dietary Supplements. Registration Seating at this workshop is very limited. To register please forward your name and complete mailing addresses including phone number via e-mail to Mr. Mike Schultz at mschultz@csionweb.com. Mr. Schultz will be coordinating the registration for this meeting. If you wish to make an oral presentation during the meeting, you must indicate this when you register and submit the following information: (1) A brief written statement of the general nature of the comments that you wish to present, (2) the names and addresses of the person(s) who will give the presentation, and (3) the approximate length of time that you are requesting for your presentation. Depending on the number of people who register to make presentations, we may have to limit the time allotted for each presentation. If you don’t have access to e-mail please call Mr. Schultz at 301–670–0270. Dated: January 13, 2009. Paul M. Coates, Director, Office of Dietary Supplements, National Institutes of Health. [FR Doc. E9–1162 Filed 1–21–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Coast Guard rmajette on PRODPC74 with NOTICES [Docket No. USCG–2007–28460] Long Range Aids to Navigation (Loran–C) Program; Draft Programmatic Environmental Impact Statement AGENCY: Coast Guard, DHS. VerDate Nov<24>2008 14:47 Jan 21, 2009 Jkt 217001 ACTION: Notice of availability and request for comments. 4047 SUMMARY: The Coast Guard announces the availability of a Draft Programmatic Environmental Impact Statement (PEIS) on the Future of the Long Range Aids to Navigation (Loran–C) Program. We request your comments on the Draft PEIS. LCDR Robert Manning, (CG–54132) Electronic Navigation Division, U.S. Coast Guard, telephone 202–372–1560, or e-mail robert.j.manning@uscg.mil. If you have questions on viewing or submitting material to the docket, call Renee V. Wright, Program Manager, Docket Operations, telephone 202–366– 9826. SUPPLEMENTARY INFORMATION: DATES: Two public meetings concerning the Draft PEIS are planned. The public meetings will be held on February 18, 2009, in Washington, DC and on March 3, 2009, in New Orleans, LA. Comments and related material must reach the Docket Management Facility on or before March 9, 2009. ADDRESSES: The Washington, DC meeting will be held at the Ronald Reagan Building and International Trade Center, Oceanic Rooms A & B, 1300 Pennsylvania Avenue, NW., Washington, DC 20004, telephone 202– 312–1326. The New Orleans, LA meeting will be held at the Hilton New Orleans Riverside, Rosedown Room, 2 Poydras Street, New Orleans, LA 70140, telephone 504–556–3739. Each meeting will consist of an informational open house from 4:30 p.m. to 6 p.m. and a public scoping meeting from 6 p.m. to 8 p.m. The public meetings may end later than the stated time, depending on the number of persons wishing to speak. Send written material or comments you wish to have as part of the meeting record to Department of Homeland Security, U.S. Coast Guard, (CG–54132) Electronic Navigation Branch, 2100 Second Street, SW., Washington, DC 20593–0001, Attn: LCDR Robert Manning no later than February 9, 2009. You may submit comments identified by Coast Guard docket number USCG– 2007–28460 to the Docket Management Facility at the U.S. Department of Transportation. To avoid duplication, please use only one of the following methods: (1) Online: https:// www.regulations.gov. (2) Mail: Docket Management Facility (M–30), U.S. Department of Transportation, West Building Ground Floor, Room W12–140, 1200 New Jersey Avenue, SE., Washington, DC 20590– 0001. (3) Hand delivery: Room W12–140 on the Ground Floor of the DOT West Building, 1200 New Jersey Avenue, SE., Washington, DC 20590, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. The telephone number is 202–366–9329. (4) Fax: 202–493–2251. FOR FURTHER INFORMATION CONTACT: If you have questions on this notice, call Public Participation and Request for Comments We encourage you to submit comments and related material on the Draft PEIS on the Future of the LoranC Program. All comments received will be posted, without change, to https:// www.regulations.gov and will include any personal information you have provided. We have an agreement with the Department of Transportation (DOT) to use the Docket Management Facility. Please see DOT’s ‘‘Privacy Act’’ paragraph below. Submitting comments: If you submit a comment, please include the docket number for this notice (USCG–2007– 28460), and give the reason for each comment. You may submit your comments and material by electronic means, mail, fax, or delivery to Docket Management Facility at the address under ADDRESSES; but please submit your comments and material by only one means. We recommend that you include your name and a mailing address, an e-mail address, or a telephone number in the body of your document so that we can contact you if we have questions regarding your submission. For example, we may ask you to resubmit your comment if we are not able to read your original submission. If you submit them by mail or delivery, submit them in an unbound format, no larger than 81⁄2 by 11 inches, suitable for copying and electronic filing. If you submit them by mail and would like to know that they reached the Docket Management Facility, please enclose a stamped, self-addressed postcard or envelope. We will consider all comments and material received during the comment period. Viewing the comments and Draft PEIS: To view the comments and the Draft PEIS, go to https:// www.regulations.gov, select the Advanced Docket Search option on the right side of the screen, insert USCG– 2007–28460 in the Docket ID box, press Enter, and then click on the item in the Docket ID column. If you do not have access to the Internet, you may view the docket online by visiting the Docket Management Facility in Room W12–140 on the ground floor of the DOT West Building, 1200 New Jersey Avenue, SE., PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\22JAN1.SGM 22JAN1

Agencies

[Federal Register Volume 74, Number 13 (Thursday, January 22, 2009)]
[Notices]
[Pages 4046-4047]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-1162]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


ODS Analytical Methods and Reference Materials Program--Dietary 
Supplement Element Methodology Workshop; Notice

    Notice is hereby given of the National Institutes of Health (NIH) 
Office of Dietary Supplements (ODS) Analytical Methods and Reference 
Materials Program, Dietary Supplement Element Methodology Workshop to 
be held Monday, March 23rd and Tuesday, March 24th, 2009 at the 
Marriott Gaithersburg Washingtonian Center Hotel in Gaithersburg, 
Maryland, 20878.
    Summary: Late in 2001, the U.S. Congress addressed the need for 
support of analytical methods and reference materials development 
related to dietary supplements. The Congressional appropriation 
language supported an increased ODS budget for several topics, 
including analytical methods and reference materials. The Senate 
language called for: ``ODS to allocate sufficient funds to speed up an 
ongoing collaborative effort to develop and disseminate validated 
analytical methods and reference materials for the most commonly used 
botanicals and other dietary supplements.''
    On February 8, 2002, ODS held a public meeting to solicit comments 
to assist ODS in designing an overall strategy for implementing the 
Congressional mandate to foster development and validation of 
analytical methods and reference materials for dietary supplements.
    In Fiscal Years 2004 and 2005, Congress again used similar language 
supporting the Analytical Methods and Reference Materials Program in 
the ODS appropriations.
    On September 10, 2007, ODS held a Stakeholders' Meeting to review 
the progress that had been made by the Analytical Methods and Reference 
Materials Program since its inception in 2002 and to receive comments 
on future programmatic directions.
    As a follow-up to the recommendations from the Stakeholders' 
Meeting, a Vitamin Methodology Workshop was held in July 2008. This 
workshop sought to evaluate the state of analytical methodology on 
vitamins suitable for dietary supplements and to identify gaps in the 
analytical science for the purpose of meeting future methods needs of 
stakeholders. Results of the Vitamin Methodology Workshop include an 
executive summary of the

[[Page 4047]]

outcome of the workshop (in preparation) as well as recognition of a 
need for a Dietary Supplement Element Methodology Workshop.
    The purpose of this upcoming workshop is to evaluate the state of 
analytical methods for nutrient and non-nutrient minerals (including 
toxic elements) in dietary supplement products and to identify gaps in 
methodology, with a view toward designing a research program to fill 
the unmet methods needs of stakeholders. The desired outcomes of this 
meeting are to provide an overview of the status of analytical 
methodology for elements, to discuss analytical method purpose 
statements, to discuss the definition and evaluation of a method's 
purpose, as well as its fitness for purpose.
    The sponsor of this meeting is the NIH Office of Dietary 
Supplements.

Registration

    Seating at this workshop is very limited. To register please 
forward your name and complete mailing addresses including phone number 
via e-mail to Mr. Mike Schultz at mschultz@csionweb.com. Mr. Schultz 
will be coordinating the registration for this meeting. If you wish to 
make an oral presentation during the meeting, you must indicate this 
when you register and submit the following information: (1) A brief 
written statement of the general nature of the comments that you wish 
to present, (2) the names and addresses of the person(s) who will give 
the presentation, and (3) the approximate length of time that you are 
requesting for your presentation. Depending on the number of people who 
register to make presentations, we may have to limit the time allotted 
for each presentation. If you don't have access to e-mail please call 
Mr. Schultz at 301-670-0270.

    Dated: January 13, 2009.
Paul M. Coates,
Director, Office of Dietary Supplements, National Institutes of Health.
[FR Doc. E9-1162 Filed 1-21-09; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.